Additionally, the antibody-positive group had higher ALT and AST levels, lower platelet (PLT) counts, and higher noninvasive liver fibrosis indices (APRI and FIB-4) (all P<.05). The gene discussed is GPT; the disease is Hepatic fibrosis.